Barrett's Esophagus (BE) Research Studies

CEDAS research studies that are currently enrolling participants with Barrett's Esophagus (BE).

Non-Endoscopic Surveillance for Barrett's Esophagus (BE) Following Ablative Therapy

Currently enrolling by invitation only

Purpose: To  determine if a new, minimally invasive sampling technique, the Cytosponge, is a well-tolerated and effective means to sample the lining of the esophagus (food tube) in patients who have previously received radiofrequency ablation for Barrett’s Esophagus (a change in the lining of the esophagus/food tube from acid reflux).
Principal Investigator: Dr. Nicholas Shaheen, MD, MPH
Sponsor
: National Institutes of Health (NIH)

Visit clinicaltrials.gov to learn more about Non-Endoscopic Surveillance for BE Following Ablative Therapy

Clinicaltrials.gov


Assessment of a Minimally Invasive Esophageal Cytology Collection System in Patients with Barrett’s Esophagus or GERD Symptoms

Currently enrolling by invitation only


Purpose: To determine if a new, minimally invasive sampling technique, the Cytosponge, is a well-tolerated and effective means to sample the lining of the esophagus (food tube) in patients who have gastroesophageal reflux disease (GERD) or Barrett’s Esophagus (a change in the lining of the esophagus/food tube from acid reflux which is when acid and other contents from your stomach irritate the lining of your esophagus/food tube).
Principal Investigator: Dr. Nicholas Shaheen, MD, MPH
Sponsor
: GI Solutions - Covidien

Visit clinicaltrials.gov to learn more about Assessment of a minimally invasive esophageal cytology collection system in patients with BE or GERD

Clinicaltrials.gov


trūFreeze™ Spray Cryotherapy Patient Registry

Currently enrolling by invitation only

Purpose: The primary objective of this registry is to collect efficacy data related to the use of truFreeze® spray cryotherapy in the pulmonary and gastrointestinal settings.
Principal Investigator: Dr. Nicholas Shaheen, MD, MPH
Sponsor
: CSA Medical, Inc.CSA medical.jpg
Contact: Jacquelyn Covington

Visit clinicaltrials.gov to learn more about truFreezeTM spray Cryotherapy Patient Registry

Clinicaltrials.gov


Genetic and Environmental Determinants of Barrett's Esophagus (BE)

Currently enrolling by invitation only

Purpose: This is a multi-center study whose aim is to define the epidemiology and genetics of Barrett’s esophagus and adenocarcinoma.
Principal Investigator: Dr. Nicholas Shaheen, MD, MPH
Sponsor: National Institute of Diabetes, Digestive, & Kidney Disease

Visit clinicaltrials.gov to learn more about Genetic and Environmental Determinants of BE

Clinicaltrials.gov


UNC Barrett's Esophagus and Esophageal Cancer Biorepository (BEECAB)

Currently Enrolling

Purpose: To learn more about Barrett’s Esophagus and esophageal cancer by collecting data and samples (blood and tissue) for a biorepository.
Principal Investigator: Dr. Nicholas Shaheen, MD, MPH
Sponsor: University of North Carolina
Contact: RoseMary Beitia

Visit clinicaltrials.gov to learn more about the BEECAB study

Clinicaltrials.gov


Eradicating Barrett’s esophagus Using Radiofrequency ablation or a Novel hybrid Argon plasma coagulation technique: BURN Trial

Not yet enrolling

Purpose: To determine the efficacy of Hybrid-Argon plasma coagulation (H-APC) compared to Radiofrequency ablation (RFA) for the eradication of dysplastic Barrett’s esophagus (BE) within 12 months after randomization.
Principal Investigator: Dr. Nicholas Shaheen, MD, MPH


Coldplay 3: Multi-Center Clinical Study to Evaluate the Coldplay CryoBalloonTM Focal Ablation System for the Treatment of Patients with Previously-Untreated Dysplastic Barrett’s Epithelium

Not yet enrolling

Purpose: To collect additional data on the efficacy and safety of the CryoBalloon System, specifically in the treatment of patients with previously untreated (treatment naïve) Barrett’s Esophagus.  
Principal Investigator: Dr. Nicholas Shaheen, MD, MPH
Sponsor: C2 Therapeutics

Visit clinicaltrials.gov to learn more about Coldplay 3

Clinicaltrials.gov


Testing Aspirin in People with Barrett's Esophagus After Successful Eradication of Barrett's Esophagus with Radiofrequency Ablation

Not yet enrolling

Purpose: To determine whether aspirin safely reduces the risk of re-developing BE after successful treatment.
Principal Investigator: Dr. Nicholas Shaheen, MD, MPH
Sponsor: University of Texas MD Anderson Cancer Center

Visit clinicaltrials.gov to learn more about Testing Aspirin in People with BE after Successful Eradication of BE with RFA

Clinicaltrials.gov



Please contact us for more information regarding any of the above active CEDAS research studies:

Return to top of page